Congresswoman Debbie Dingell (MI-06) today announced that the University of Michigan will receive $9,879,697 in federal grant funding from the Department of Health and Human Services (HHS) to conduct research in areas including pharmacology, physiology, and biological chemistry, blood diseases and resources, cancer biology, treatment detection, and diagnosis, lung diseases, heart and vascular diseases, allergy, immunology, and transplantation, arthritis, musculoskeletal, skin diseases, and other areas.
More than $2.1 million of this funding will be dedicated to lung diseases research.
“Lung cancer is the leading cause of cancer deaths in the U.S., and millions more live with chronic lung disease," said Dingell. "We must invest in research and development of new therapies and treatments that enable patients and providers to access the best possible resources and improve outcomes, and this funding will empower UM to continue that important research."
Additional projects receiving funding include:
- $2,034,994 for Pharmacology, Physiology, and Biological Chemistry Research
- $1,167,409 for Heart and Vascular Diseases Research
- $988,138 for Blood Diseases and Resources Research
- $940,816 for tMichigan Embedded LHS Scientist Training and Research (MEL-STaR) Center
- $749,543 for Diabetes, Endocrinology and Metabolic Research
- $541,481 for Allergy, Immunology, and Transplantation Research
- $425,470 for Cancer Detection and Diagnosis Research
- $309,441 for Arthritis, Musculoskeletal and Skin Diseases Research
- $292,573 for Cancer Biology Research
- $218,790 for Cancer Treatment Research
Find a full list of projects receiving grant funding here.
HHS is the largest grant-making agency in the US. Most HHS grants are provided directly to states, territories, tribes, and educational and community organizations, then distributed to eligible individuals and organizations. For more information on HHS grants click here.
